Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC

ClinicalTrials.gov ID: NCT03298022

Public ClinicalTrials.gov record NCT03298022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 5:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of ALTB-168 in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial

Study identification

NCT ID
NCT03298022
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AltruBio Inc.
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • ALTB-168 Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 3, 2018
Primary completion
Apr 5, 2020
Completion
May 31, 2020
Last update posted
Jan 4, 2024

2018 – 2020

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Lynn Institute of the Ozarks Little Rock Arkansas 72205
Stomach Doctor - Surinder Saini, MD - Fountain Valley Newport Beach California 92660
Wellness Clinical Research (WCR) Hialeah Florida 33016-2202
Wellness Clinical Research (WCR) Lake Wales Florida 33853
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
University of Chicago Chicago Illinois 60637
Capitol Research Rockville Maryland 20850
Weill Cornell Medical College New York New York 10021
University of Rochester Medical Center Rochester New York 14642
Baylor College of Medicine Houston Texas 77030
University of Washington Medical Center (UWMC) - Digestive Disease Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03298022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2024 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03298022 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →